LP_(LDL) achieves GRAS status

摘要

OptiBiotix Health PLC, a life sciences business developing compounds to tackle obesity, cardiovascular disease and diabetes, has announced that its revolutionary probiotic ingredient LP_(LDL)® has achieved full Generally Recognised As Safe (GRAS') status. Next-generation ingredient LP_(LDL)®, supplied by fully owned subsidiary ProBiotix Health Ltd ('ProBiotix'), improves blood lipid profiles and blood pressure. Discovered using OptiBiotix' unique screening process and probiotic research to offer a natural, science-backed and non-pharmaceutical approach to physical health. To achieve this, LP_(LDL)® harnesses the microbiome-liver axis to impact positively on the gut microbiome using a naturally occurring strain of the bacterial species Lactobacillus plantarum.